Shi Y F, Sahai B M, Green D R
Department of Immunology, University of Alberta, Edmonton, Canada.
Nature. 1989 Jun 22;339(6226):625-6. doi: 10.1038/339625a0.
One mechanism by which the immune system develops the ability to discriminate self from nonself is the deletion of autoreactive T-cell clones during thymic maturation. The drug cyclosporin A (CsA) has been shown to interfere with this process, allowing the escape of normally 'forbidden' T-cell clones and the appearance of autoimmune disease. Recently, it has been demonstrated that immature thymocytes undergo programmed cell death (apoptosis) upon activation via the T-cell receptor. A similar phenomenon of activation-induced cell death (AICD) has been observed in T-cell hybridomas. Here we show that AICD in T-cell hybridomas in vitro and in thymocytes in vivo is blocked by CsA. Thus, clonal deletion may involve AICD when self-reactive, immature T cells are induced by self antigen, and CsA may cause autoimmunity by interfering with this process.
免疫系统形成区分自身与非自身能力的一种机制是在胸腺成熟过程中清除自身反应性T细胞克隆。药物环孢菌素A(CsA)已被证明会干扰这一过程,使正常情况下“被禁止”的T细胞克隆逃脱并引发自身免疫性疾病。最近,已证明未成熟胸腺细胞在通过T细胞受体激活后会经历程序性细胞死亡(凋亡)。在T细胞杂交瘤中也观察到了类似的激活诱导细胞死亡(AICD)现象。在此我们表明,体外T细胞杂交瘤和体内胸腺细胞中的AICD被CsA阻断。因此,当自身反应性未成熟T细胞被自身抗原诱导时,克隆清除可能涉及AICD,而CsA可能通过干扰这一过程导致自身免疫。